# A Study of Axitinib in Advanced Carcinoid Tumors

> **NCT01435122** · PHASE2 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 30 (actual)

## Conditions studied

- Carcinoid Tumor

## Interventions

- **DRUG:** Axitinib

## Key facts

- **NCT ID:** NCT01435122
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-25
- **Primary completion:** 2017-01-11
- **Final completion:** 2018-02-13
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-10-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01435122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01435122, "A Study of Axitinib in Advanced Carcinoid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01435122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*